These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 32450787)

  • 1. Liver injury in COVID-19: The current evidence.
    Alqahtani SA; Schattenberg JM
    United European Gastroenterol J; 2020 Jun; 8(5):509-519. PubMed ID: 32450787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same.
    Olry A; Meunier L; Délire B; Larrey D; Horsmans Y; Le Louët H
    Drug Saf; 2020 Jul; 43(7):615-617. PubMed ID: 32514859
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 and hepatitis.
    Trevenzoli M; Guarnaccia A; Alberici I; Fassan M; Di Meco E; Farinati F; Cattelan AM
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):473-475. PubMed ID: 32919428
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and liver disease: An update.
    Téllez L; Martín Mateos RM
    Gastroenterol Hepatol; 2020 Oct; 43(8):472-480. PubMed ID: 32727662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Abnormal liver function tests.
    Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
    J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical manifestations and management of COVID-19-related liver injury.
    Su TH; Kao JH
    J Formos Med Assoc; 2020 Jun; 119(6):1016-1018. PubMed ID: 32345544
    [No Abstract]   [Full Text] [Related]  

  • 8. Current Perspective of Antiviral Strategies against COVID-19.
    Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
    ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of liver injury in COVID-19 - a German case series.
    Schattenberg JM; Labenz C; Wörns MA; Menge P; Weinmann A; Galle PR; Sprinzl MF
    United European Gastroenterol J; 2020 Aug; 8(7):814-819. PubMed ID: 32588791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients.
    Liao S; Zhan K; Gan L; Bai Y; Li J; Yuan G; Cai Y; Zhang A; He S; Mei Z
    Signal Transduct Target Ther; 2020 Oct; 5(1):255. PubMed ID: 33130825
    [No Abstract]   [Full Text] [Related]  

  • 13. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
    Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
    J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.
    Shah S; Danda D; Kavadichanda C; Das S; Adarsh MB; Negi VS
    Rheumatol Int; 2020 Oct; 40(10):1539-1554. PubMed ID: 32666137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19.
    Muhović D; Bojović J; Bulatović A; Vukčević B; Ratković M; Lazović R; Smolović B
    Liver Int; 2020 Aug; 40(8):1901-1905. PubMed ID: 32478465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-19: a cardiological point-of-view].
    Weckbach LT; Kellnar A; Stremmel C; Stark K; Kääb S
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1063-1067. PubMed ID: 32731280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of coronavirus disease 2019.
    Hung IFN
    Curr Opin HIV AIDS; 2020 Nov; 15(6):336-340. PubMed ID: 33002954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
    Ali N
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):e84-e86. PubMed ID: 32471656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.